A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Intention |
---|---|
Submitter | Netherlands |
Regulatory programme |
|
Further substance information | Spinosyn A: CAS nr 131929-60-7 (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione Spinosyn D: CAS nr 131929-63-0 (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-as-indaceno[3,2-d]oxacyclododecine-7,15-dione |
Remarks | Active substance spinosad (CAS: 168316-95-8) exists of a mix of two substances; spinosyn A (CAS: 131929-60-7) and spinosyn D (CAS: 131929-63-0)Spinosyn A: Indexnr 603-209-00-0 H400, H410, M=10 Spinosyn D: Indexnr 603-209-00-0 H400, H410, M=10 |
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Intention timeline
Date of intention | 2018-02-20 |
---|---|
Expected date of submission | 2018-11-30 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Sept. 24, 2019
- Expected date of submission: 2018-11-30 → 2022-11-30
March 12, 2020
- Submitter email: bureau-reach@rivm.nl
March 31, 2021
- Name: spinosad (ISO); Reaction mass of Spinosyn A: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione and Spinosyn D: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2.3.4.6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethy-2,3,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione → Spinosad;Spinosad as a mixture of 50-95 % spinosyn A and 5-50 % spinosyn D.
April 8, 2021
- Name: Spinosad;Spinosad as a mixture of 50-95 % spinosyn A and 5-50 % spinosyn D. → spinosad (ISO); Reaction mass of Spinosyn A: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethyl-2,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione and Spinosyn D: (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-L-mannopyranosyloxy)-13-(4-dimethylamino-2.3.4.6-tetradeoxy-β-D-erythropyranosyloxy)-9-ethy-2,3,3a,5a,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeaca[b]as-indacene-7,15-dione
This version
Add any of the related substances to your watchlist to monitor this regulatory record.